Home » Topics » Regulatory » Patents

Patents
RSS

Novel protein kinase inhibitors manufactured at Abbott

Jan. 30, 2009

Roche divulges antipsychotic tachykinin NK3 receptor antagonists

Jan. 30, 2009

New cathepsin K inhibitors developed at AstraZeneca

Jan. 30, 2009

Argenta and AstraZeneca jointly impart novel muscarinic M3 receptor antagonists

Jan. 30, 2009

Histamine H3 receptor modulators for treating obesity developed at Roche

Jan. 30, 2009

Kyowa Hakko Kirin describes novel antitumor agents

Jan. 29, 2009

New chemokine CXCR5 receptor antagonists prepared and tested at sanofi-aventis

Jan. 29, 2009

Roche claims novel PI3K inhibitors with potential as anticancer agents

Jan. 29, 2009

Schering-Plough announces the development of Aurora kinase inhibitors

Jan. 29, 2009

Novel PDE inhibitors in development at Kyorin for the treatment of respiratory disorders

Jan. 29, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...